| Net Cash Provided by (Used in) Operating Activities |
$16,039,000 |
USD |
-9.4% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$70,885,000 |
USD |
87% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$71,281,000 |
USD |
-87% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
17,721,828 |
shares |
1.5% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$16,435,000 |
USD |
523% |
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$7,518,000 |
USD |
11% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Issued |
1,645,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
1,645,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$1,079,000 |
USD |
-53% |
Q1 2025 |
Q1 2025 |
| Interest Expense |
$50,588,000 |
USD |
16% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |